Category: Blood Test
The AFP (Alpha-Fetoprotein) Tumor Marker Test is a blood test used to measure the level of alpha-fetoprotein (AFP) in the bloodstream. AFP is a protein that is naturally produced in large amounts by a developing fetus. During pregnancy, AFP is mainly produced by the fetal liver and yolk sac. After birth, AFP levels normally decrease significantly and remain relatively low in healthy adults.
In adults, an elevated AFP level can sometimes be associated with certain cancers, particularly hepatocellular carcinoma (HCC), which is the most common primary cancer of the liver. AFP may also increase in some germ cell tumors, especially certain non-seminomatous testicular and ovarian tumors.
However, AFP is not a cancer-specific substance. Increased AFP levels can also occur because of non-cancerous liver conditions, including chronic hepatitis and cirrhosis. For this reason, an elevated AFP result does not automatically mean that a person has cancer.
The AFP test is therefore usually interpreted together with the patient's symptoms, medical history, physical examination, liver function tests, and imaging studies such as ultrasound, CT scan, or MRI.
The test can be especially useful for people who already have chronic liver disease and are being monitored for possible liver cancer. In some high-risk patients, AFP may be measured along with liver imaging as part of a surveillance strategy, according to the healthcare provider's recommendations.
AFP can also be used to monitor people who have already been diagnosed with certain cancers. If AFP was elevated before treatment, repeated measurements may help doctors assess how the tumor is responding to treatment. A decrease in AFP may indicate a response, while a persistent or increasing level may require further evaluation.
The AFP test may also be used to monitor for cancer recurrence after treatment when AFP was previously elevated.
It is important to understand that AFP testing has limitations. Some people with liver cancer have normal AFP levels, while some people without cancer may have significantly elevated AFP. Therefore, AFP should not be used as a standalone diagnostic test.
AFP is also used in a different context during pregnancy, where maternal AFP testing can be part of prenatal screening. Pregnancy-related AFP testing has different purposes and reference ranges from AFP tumor-marker testing in non-pregnant adults.
The main purpose of the AFP Tumor Marker Test is to help evaluate and monitor certain cancers, particularly liver cancer and specific germ cell tumors.
One of its most important applications is in people with chronic liver diseases such as cirrhosis or chronic hepatitis B or hepatitis C infection. These conditions can increase the risk of developing hepatocellular carcinoma.
In people at increased risk, doctors may use liver imaging, particularly ultrasound, with or without AFP measurement depending on the patient's circumstances and applicable clinical guidelines.
AFP may also be requested when a healthcare professional suspects liver cancer based on symptoms, abnormal liver tests, or imaging findings.
Possible symptoms associated with liver cancer can include:
Unexplained weight loss
Loss of appetite
Persistent abdominal discomfort
A feeling of fullness in the upper abdomen
Unexplained weakness or fatigue
Yellowing of the skin or eyes
Abdominal swelling
Unexplained worsening of liver function
These symptoms can also occur in many other liver and digestive conditions, so AFP testing alone cannot determine the cause.
Another purpose of AFP testing is monitoring treatment in patients who have already been diagnosed with AFP-producing cancer.
For example, a patient with hepatocellular carcinoma may have an elevated AFP level before treatment. After surgery, ablation, chemotherapy, or another treatment, AFP may be measured again.
If AFP decreases significantly, it may be consistent with a reduction in tumor activity. If AFP remains elevated or rises again, the healthcare team may investigate whether there is remaining or recurrent disease.
AFP may also be used in the evaluation of certain testicular or ovarian germ cell tumors, especially non-seminomatous germ cell tumors. In these cases, AFP is often measured alongside other tumor markers such as beta-hCG and LDH.
AFP can also help with staging and treatment monitoring in certain germ cell cancers.
However, AFP is not elevated in every type of germ cell tumor. For example, pure seminoma does not generally produce AFP. Therefore, the marker pattern can provide useful information when combined with other tests.
Another important purpose is helping doctors evaluate an unexplained elevation of AFP. If the result is abnormal, additional testing may be required to determine whether the increase is related to liver disease, pregnancy, a tumor, or another cause.
The test can also provide a baseline value before treatment so that future results can be compared.
Overall, the purpose of the AFP Test is to support the evaluation of certain liver and germ cell cancers, monitor treatment response, assess possible recurrence, and provide additional information in patients at increased risk of specific tumors.
Preparation for an AFP Tumor Marker Test is generally simple. Fasting is usually not required when AFP is the only blood test being performed.
However, if AFP is ordered along with other tests that require fasting, the healthcare provider or laboratory may provide fasting instructions.
Patients should follow the specific instructions given by the laboratory.
The test requires a small blood sample, usually collected from a vein in the arm.
Patients should inform the healthcare professional about all medications, vitamins, supplements, and medical conditions.
It is particularly important to mention any history of:
Liver disease
Hepatitis
Cirrhosis
Previous cancer
Testicular or ovarian tumors
Recent cancer treatment
Pregnancy
Pregnancy is especially important to report because AFP levels naturally increase during pregnancy, and pregnancy has completely different AFP reference ranges.
Patients should not stop prescribed medicines before the test unless instructed by their healthcare provider.
The blood collection normally takes only a few minutes. A healthcare professional inserts a small needle into a vein and collects the required blood sample.
Some people may experience mild discomfort, bruising, or tenderness at the collection site.
If AFP is being used to monitor cancer treatment, the doctor may schedule the test at specific intervals. Repeated measurements may be more useful when performed using the same laboratory or testing method, because laboratory methods can vary.
Patients should also tell their healthcare provider if they have recently undergone surgery, chemotherapy, radiation, ablation, or another cancer treatment.
If AFP is being measured because of suspected liver disease, other blood tests may be performed at the same time, including ALT, AST, bilirubin, albumin, and other liver function tests.
No special recovery period is usually required after the blood sample is collected.
The normal range for the AFP Tumor Marker Test can vary depending on the laboratory, testing method, age, sex, and pregnancy status.
For non-pregnant adults, a commonly used reference range is approximately:
AFP: Less than 10 ng/mL
Some laboratories may use a slightly different upper reference limit, such as less than 7 ng/mL or another value.
Therefore, the reference range printed on the laboratory report should always be used.
A simplified interpretation is:
Normal AFP: The AFP level is within the laboratory's expected range.
Elevated AFP: The AFP level is higher than expected and may require further investigation.
An elevated AFP level does not automatically indicate cancer.
AFP can increase in several non-cancerous conditions, especially those involving the liver. These include:
Chronic hepatitis
Liver inflammation
Cirrhosis
Liver regeneration after injury
Certain other liver diseases
AFP also naturally increases during pregnancy because it is produced by the developing fetus.
In some cases, AFP may be elevated in newborns and young infants because their AFP levels are naturally higher after birth and gradually decrease.
For liver cancer, AFP can be elevated in a significant proportion of patients with hepatocellular carcinoma, but not all liver cancers produce AFP. This means that a normal AFP cannot completely rule out liver cancer.
Similarly, an elevated AFP does not confirm liver cancer. Imaging and sometimes tissue examination are needed to establish a diagnosis.
When AFP is used for cancer monitoring, changes over time can be more informative than one isolated value.
For example, if a patient with confirmed AFP-producing liver cancer has a high AFP level before treatment and the level decreases after treatment, this may suggest that the tumor burden has decreased.
If AFP remains high or begins increasing again, doctors may investigate for residual disease, recurrence, or progression.
However, changes in AFP can also result from liver inflammation or other non-cancerous conditions, so the result must be interpreted carefully.
In patients with suspected liver cancer, additional investigations may include:
Liver ultrasound
CT scan
MRI
Liver function tests
Hepatitis testing
Other tumor markers
Additional specialized investigations
For suspected germ cell tumors, AFP may be interpreted with beta-hCG and LDH, along with imaging and physical examination.
AFP levels can sometimes be very high in certain germ cell tumors, but the exact significance depends on the type and stage of the tumor.
It is important not to compare AFP results from different laboratories without considering their reference ranges and testing methods.
Overall, the AFP (Alpha-Fetoprotein) Tumor Marker Test is an important blood test used mainly in the evaluation and monitoring of hepatocellular carcinoma and certain germ cell tumors. A commonly used adult reference value is less than 10 ng/mL, although laboratory ranges vary. Elevated AFP can occur with cancer as well as non-cancerous conditions such as hepatitis and cirrhosis, while some patients with cancer may have normal AFP levels. Therefore, AFP is not a standalone cancer diagnostic test. It is most useful when interpreted with imaging studies, liver function tests, other tumor markers, medical history, and changes in AFP levels over time. In pregnant women, AFP has a separate clinical purpose and must be interpreted using pregnancy-specific reference ranges.
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider. In an emergency, call emergency services immediately.